Phone-based nurse support for breast cancer medication side effects
Part of Cancer, Skin clinical trials.
This study tests whether regular phone check-ins with a nurse can help catch and manage side effects from CDK4/6 inhibitor medications (like palbociclib, ribociclib, or abemaciclib) that you're taking for breast cancer. The goal is to help you stay on treatment safely and feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have been diagnosed with breast cancer (confirmed by biopsy)
- You are currently taking a CDK4/6 inhibitor medication for your breast cancer
- You have access to a phone or device to communicate with the study nurse
- You are able and willing to take part in regular check-in calls
- You do not have serious cognitive or psychiatric conditions that would make participation difficult
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well people stick to a treatment plan that combines hormone therapy with a pill called a CDK4/6 inhibitor after surgery for early-stage breast cancer. The goal is to learn more about adherence so doctors can help patients stay on track.
This study tests a new way of monitoring patients with advanced breast cancer who are already taking hormone therapy and a CDK4/6 inhibitor. The goal is to see if remote monitoring can improve care and quality of life.
This trial tests whether regular phone calls from a nurse can help patients after they finish their main cancer treatment. It focuses on breast, colorectal, or prostate cancer that was treated with a goal to cure.
This trial looks at what happens when women with advanced hormone-positive, HER2-negative breast cancer stop taking a CDK4/6 inhibitor after at least a year of successful treatment. The goal is to see if it's safe to take a break from the CDK4/6 inhibitor while continuing hormone therapy alone.
This study looks at how well CDK4/6 inhibitors (a type of targeted therapy) work in real-world patients with HR+/HER2- advanced breast cancer. By collecting medical data from people treated at this hospital, doctors hope to learn more about the effectiveness and safety of these drugs in everyday practice.
This study tests whether using an online health portal to report side effects during chemotherapy for breast cancer helps reduce their severity. You will be asked to regularly log how you feel, so your care team can respond sooner.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.